Equest Horse Wormer (Moxidectin) Treats 700kg
Read more about this product »
- Equest Horse Wormer 700kg
- Dosage and Administration
- Contra-indications & Warnings
- Further Information
EQUEST ORAL GEL - HORSE WORMER
Over 90% of all small redworm found in your horse will be encysted larvae. These will not show up on an egg count so the level of infection can be difficult to assess. Because of the unique way Moxidectin (the active Ingredient in Equest) works, Equest is the only wormer licensed to control all stages of encysted small redworm in a single dose. (It does not cover Tapeworms.) IT IS SUITABLE FOR FOALS OVER 4 MONTHS AND PREGNANT MARES. It has a remarkably long duration of action worming horses for 13 weeks. Equest also remains in the horses system for a further 2 weeks once treated thereby reducing the horses risk of re-infection and pasture contamination. Equest also has a lower toxicity to dung dwelling insects than the Ivermectin based wormers. This again reduces pasture contamination as these insects help clear the pastures of dung.
Equest is also highly economical as only 4 single doses are required for year round bot and roundworm control. This long dosing interval may also reduce the risk of resistance building up. Wastage is also reduced due to the unique clear gel formula which melts in your horses mouth meaning there will be no more spat out paste.
If tapeworm cover is needed you can alternate Equest with Equest Pramox every 3 months or a dose of EQUITAPE (Praziquantel), or a double dose of PYRANTEL (Pyratape P or Strongid P) horses wormer may be given at the beginning or end of the grazing season to complete your annual worming programme.
After opening, use within 6 months.
Shelf life is 24 months from date of manufacture.
Do not store above 25°C.
These products, as well as being available from vets and pharmacists, can be supplied by a suitably qualified person (SQP) from a pharmacy registered with the General Pharmaceutical Council (GPhC) and from premises approved by the Veterinary Medicines Directorate (VMD). Our SQP Mrs Diane Harris, number QE7160, is available for advice regarding worming schedules and procedures if required.
Within the current legislation it is our duty to determine the purchaser is a legitimate buyer and owner of an animal requiring treatment. Upon completion of purchasing these goods you will be asked some questions regarding the animal for compliance with the Veterinary Medicines Regulations, please be aware that we may contact you to confirm any details if necessary.
If you are buying a medicine for a horse that is NOT signed out of the food chain (section IX of its passport) you should ensure that the product is suitable
Always read the instructions before use.
Safety precautions may be necessary during administration, please consult the packaging and/or product literature.
This is for food producing animals.
For oral administration. One Equest Oral Gel 14.8g syringe contains sufficient gel to treat one 700kg horse at the recommended dose rate (0.4 mg moxidectin/kg bodyweight). Each graduation on the calibrated syringe delivers sufficient gel to treat 25kg bodyweight. Use of a scale or weigh tape is recommended to ensure accurate dosing. To avoid overdosing, care should be taken to accurately dose foals, especially low bodyweight foals or young ponies.
The persistent activity of EQUEST Oral Gel and its effectiveness against inhibited and developing larvae in the intestinal mucosa enables a reduction in the dosing frequency in strategic parasite control programmes. The recommended dosing interval for the control of small redworm is 13 weeks.
Consult your veterinary surgeon for the appropriate programme for your specific needs.
Horses must not be slaughtered for human consumption within 32 days of treatment.
Do not administer to young foals less than 4 months of age.
EQUEST Oral Gel is formulated specifically for use in horses only. Dogs or cats may be adversely affected by the concentration of moxidectin in this product if they are allowed to ingest spilled paste or have access to used syringes.
Do not use the same syringe to treat more than one animal unless horses are running together or in direct contact with each other on the same premises.
Do not smoke, drink or eat while handling the product. The use of protective gloves is recommended. Wash hands or any exposed area after use.
Avoid direct contact with skin and eyes. In the event of eye contact, flush the eye with copious amounts of clean water and seek medical advice.
For animal treatment only.
Keep out of the reach of children.
Read entire package insert before use.
EQUEST Oral Gel is toxic to fish and aquatic organisms. Do not contaminate ponds, waterways or ditches with product or used syringes. Dispose of any unused product and empty syringes in accordance with guidance from your local waste regulation authority.
EQUEST Oral Gel is safe to use in foals over 4 months of age, mares, stallions, ponies and horses.
Mares may be treated at any stage of pregnancy and lactation. Transient adverse reactions may occur at twice the recommended dose in foals and 3 times the recommended dose in adults. The signs are depression, inappetence, ataxia and drooping lower lip 8 to 24 hours following dosing. Symptomatic treatment is not generally necessary and recovery is generally complete within 24 to 72 hours. There is no specific antidote.
EQUEST Oral Gel is specially formulated to be easily expelled by the syringe plunger. Once in the horse`s mouth, EQUEST Gel liquefies. This facilitates dosing and reduces the risk of rejection.